Navigation Links
Prevent Blindness America Invites Consumers to 'See America' Through Nationwide Contest
Date:4/14/2008

Contest Seeks to Educate Public About the Importance of Regular Eye Care

CHICAGO, April 14 /PRNewswire/ -- Prevent Blindness America today announced the nationwide launch of its "See America" contest, an effort to educate Americans about the importance of preventive eye exams to promote overall vision health. The national non-profit group dedicated to preventing blindness and preserving sight will award the grand prize winner with the opportunity to "See America" with four complimentary plane tickets to any United States destination of their choice, provided by Orbitz.com, a leader in online travel. The first runner-up will receive two complimentary plane tickets.

The "See America" contest is open to all those affected by impaired vision or vision loss who feel as though they have "missed" important moments in their lives. From April 14 through July 31, entrants are asked to submit stories about a time in their life that they have had to sacrifice due to poor eye health. A secondary component of the contest submission is to include a destination within the United States that entrants want to visit if they win and why that destination is so important to them. Families of the visually impaired are also invited to submit nominations.

"Through this contest, we are hoping to remind consumers of what they could be missing without their vision," said Mildred M.G. Olivier, M.D., chief executive officer of the Midwest Glaucoma Center. "Regular eye care is a great way to protect our quality of life."

Research shows that diabetic retinopathy affects more than 4.4 million Americans, with cataracts affecting more than 22 million Americans. Eye diseases such as glaucoma and macular degeneration affect 2.2 million and 2 million respectively. Further, a 2007 study conducted by Prevent Blindness America showed the estimated costs associated with adult vision problems in the United States to be $51.4 billion. Fortunately, half of all cases of blindnes
'/>"/>

SOURCE Prevent Blindness America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Allegro Diagnostics Announces Publication in Cancer Prevention Research of Prediction Model for Lung Cancer Diagnosis Integrating Clinical and Genomic Features
2. MRI and PET/CT can prevent unnecessary treatment of some cervical cancer patients
3. Joint Commission Alert: Prevent Pediatric Medication Errors
4. Suicide Data on Web Mostly Not Preventive
5. Pennsylvania Attorney General Corbett, American Lung Association & Others Call for New MSA Funds to Be Used for Tobacco Prevention and Cessation
6. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
7. Its neck-and-neck down the long stretch for 2 stroke-prevention procedures
8. RF Technologies Assists Healthcare Providers in Avoiding Preventable Injury Conditions to be Denied Reimbursement by Medicare
9. Stenting as Good as Surgery for Stroke Prevention
10. Photos: New Smoking Prevention Program Launched in Schools
11. Omega-3 Fatty Acids Wont Prevent Crohns Relapse

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... Award-winning author James A. Feinst...ook, Short White Coat: Lessons from Patients on Be... the third year of medical school--the grueling cl...IA, PA (PRWEB) December 2, 2009 -- Most people wi...es dressed in a tiny hospital gown or staring at s...
(Date:12/2/2009)... SAN DIEGO, Dec. 2 Gen-P... the 21st Annual Piper Jaffray Health Care Confere...ion is scheduled to be webcast live and may be acc...en-Probe,s website at www.gen-probe.com . The web...vent. ,, About Gen-Probe ,, Gen-Probe Inc...
(Date:12/2/2009)... JOHANNESBURG, Dec. 2 LeapFrog Inv... million) investment in AllLife, the innovative So... and diabetes. The investment brings together Leap...and AllLife, one of Africa,s most innovative insur... World AIDS Day. ,, "AllLife has developed a di...
(Date:12/2/2009)...esults of a large-scale clinical trial presented t...iety of North America (RSNA) provide the first str...trasound for women with dense breasts who are at e...tudy confirmed that MRI is highly sensitive in dep...ual screening with ultrasound in addition to mammo...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlinke...is available in its catalogue: ,, The Future o...arket Forecasts to 2015, Competitive Benchmarking,...//www.reportlinker.com/p0166814/The-Future-of-Cent...Forecasts-to-2015-Competitive-Benchmarking-Product...
Breaking Medicine News(10 mins):Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Annual screening with breast ultrasound or MRI could benefit some women 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22
...://www.EvasVillage.org ), a comprehensive New Jers...se in need in 2009, and a decline in foundation gr...on, New Jersey, seeks additional funding to meet t...grams and a decline in foundation grants and gift...
...portunities for improvement amidst high satisfacti...ocus) May 27, 2009 -- Nursing home consumer satisf...hile workforce satisfaction is at its highest leve...nt research firm My InnerView shows a majority (...
... sector can play a leadership role in reducing the...educing its climate footprint. These efforts, som...e the serious health threats posed by global warmi... Without Harm. , , "By reducing its climate footp...
...ked together to develop a computer model to help a...influenza. The tool can help estimate false negati...reening process, and so assess the risk of infecte...hland, Washington, and teams at Oak Ridge National...
...Central Valley , , MOUNTAIN VIEW, Calif., May 26 ...nd leading providers of kidney dialysis services a...nnounced their participation at the National Kidne... Satellite Healthcare,s commitment to kidney healt...
...for four hours before they allowed him to enter th...ingerprints to disappear. His oncologist is now ad...ith the commonly used drug, capecitabine, to carry... [1], published online today (Wednesday 27 May). A...
Other Medicine News:Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 2Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 3Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 4Health News:Eva's Village, a Comprehensive New Jersey Anti-Poverty charity, Seeks Additional Funding to Meet the Increasing Need Along with a Decline in Donations 5Health News:Nursing Home Consumer, Workforce Satisfaction Reaches New Highs 2Health News:World Health Organization Says Health Sector Can Lead the Fight Against Climate Change 2Health News:Pandemic passenger screening 2Health News:Satellite Healthcare Walks for Kidney Health 2Health News:Cancer drug causes patient to lose fingerprints and be detained by US immigration 2
(Date:12/1/2009).... 1 Former New Jersey As...ed when his radiotherapy treatment sessions for pr...to less than five. Midway through his course of t...Cancer Center acquired the region,s first Rapid...ical Systems (NYSE: VAR ), making it possible fo...
(Date:12/1/2009)... 1 The educational resou...mproving Life," created by Lilly USA (NYSE: LLY ...om/value_of_medicine.jsp . The booklet supports Li..." and encourages an open dialogue with patients, p...al industry practices. ,, "Today, Lilly and ot...
(Date:12/1/2009)...tCall/ -- WebMD Health Corp. (Nasdaq: WBMD ), the...nced the honorees of the 2009 WebMD Health Heroes ...r Americans with extraordinary stories of personal...elp others achieve better health. ,, (Photo...Y18114 ) ,, "WebMD is honoring its 2009 Health...
Breaking Medicine Technology:Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 2Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 3Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 4Fighting Prostate Cancer With Speed and Accuracy: RapidArc(R) Radiotherapy Available at the Delaware Valley Urology Cancer Treatment Center 5Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 2Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 3Lilly Releases Latest 'Value of Medicine' Resource Guide About Key Issues Facing the Pharmaceutical Industry 4WebMD Announces 2009 Health Heroes 2WebMD Announces 2009 Health Heroes 31 scan per patient is not always enough 59758 11 scan per patient is not always enough 59758 2Catching a killer one spore at a time 10417 1Catching a killer one spore at a time 10417 2PETAs push for changes in USDA testing pays off for animals 10415 1
...iles Additional Data to the NEBIDO NDA ...XINGTON, Mass., Jan. 22 Indevus,Pharmaceuticals, ...ositive,results from its Phase III program for NEB...ctable testosterone therapy under development for ... announced today has been,filed with the U.S. Food...
... Trial to Evaluate Anti-Tumor Activity of Bavituxi...nd Paclitaxel-, TUSTIN, Calif., Jan. 22 Peregrin...al stage biopharmaceutical,company developing mono...hepatitis C virus (HCV) infection, today announced...tuximab in combination with chemotherapy in,patien...
Other Medicine Technology:Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 2Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 3Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 4Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 5Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R) 6Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 2Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 3Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer 4
...tural anatomy of the eyelid for maximum patient co...nstrument for ease of insertion. Easily removal wi...fer a slightly smaller bulb for easier insertion. ...shed silicone as the plugs with slanted collarette...
Crawford Hook
Mini MONOKA
...hread-guide reducing time and trauma in lacrimal d...ed into the nasolacrimal duct and a thin prolene t...ithdrawn leaving the polypropylene thread to pull ...thin Polyvinylpyrrolidone (PVP) coating that makes...
Medicine Products: